AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.650
-0.060 (-2.21%)
Aug 28, 2026, 4:00 PM EDT - Market closed
AC Immune Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, AC Immune stock has a consensus rating of "Strong Buy" and an average price target of $8.58. The average 1-year stock price forecast is 223.77% higher than the current stock price, while the lowest is $5.38 (+103.02%) and the highest is $11.93 (+350.19%).
Price Target: $8.58 (+223.77%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for AC Immune stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +352.83% | Aug 24, 2026 |
| BTIG | BTIG | Buy Maintains $8 | Buy | Maintains | $8 | +201.89% | Aug 21, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 7, 2026 |
Financial Forecast
Revenue This Year
18.47M
from 3.57M
Increased by 416.90%
Revenue Next Year
89.19M
from 18.47M
Increased by 382.93%
EPS This Year
-0.41
from -0.70
EPS Next Year
0.50
from -0.41
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CHF.